Archive for Coronavirus [CoV]
Evaluating and Reporting Persons Under Investigation (PUI) Source: Evaluating and Reporting Persons Under Investigation (PUI)
Continue Reading →
COVID-19 Travel Recommendations by Country Source: COVID-19 Travel Recommendations by Country
Continue Reading →
Cases in U.S. Source: Cases in U.S.
Continue Reading →
Fact sheet print resources Source: Print Resources
Continue Reading →
Depending on your travel history, you will be asked to stay home for a period of 14 days from the time you left an area with widespread or ongoing community spread. Source: Travelers from Countries with Widespread Sustained (Ongoing) Transmission Arriving in the United States
Continue Reading →
Testing in the U.S. Source: Testing in the U.S.
Continue Reading →
Global case numbers are reported by the World Health Organization (WHO) in their coronavirus disease 2019 (COVID-19) situation report. For U.S. information, visit CDC’s COVID-19 in the U.S. Source: Global case numbers are reported by the World Health Organization (WHO)
Continue Reading →
This interim guidance is to help community- and faith-based organizations (CFBOs), whose members may include vulnerable populations, plan for community transmission of coronavirus disease (COVID-19) in the United States. Source: Get Your Community- and Faith-Based Organizations Ready for Coronavirus Disease 2019
Continue Reading →
This page includes information about Coronavirus Disease 2019 (COVID-19) for travelers and travel-related industries. Source: Coronavirus Disease 2019 Information for Travel (New Travel Alerts)
Continue Reading →
There are no US Food and Drug Administration (FDA)-approved drugs specifically for the treatment of patients with COVID-19. At present clinical management includes infection prevention and control measures and supportive care, including supplementary oxygen and mechanical ventilatory support when indicated. An array of drugs approved for other indications as well as several investigational drugs are […]
Continue Reading →